<?xml version="1.0" encoding="UTF-8"?>
<p id="p0275">GBS can occur post gastrointestinal or respiratory illness. The suggested mechanism is molecular mimicry in which the pathogen likely share epitopes similar to the components of the peripheral nerves. The antibodies produced by the host immune system to fight the virus, cross-react and bind to the peripheral nerves causing neuronal dysfunction. [
 <xref rid="bb1245" ref-type="bibr">249</xref>] AIDP and AMAN variants have been reported after SARS-CoV-1 and MERS-CoV infections. [
 <xref rid="bb0125" ref-type="bibr">25</xref>,
 <xref rid="bb0170" ref-type="bibr">34</xref>,
 <xref rid="bb0230" ref-type="bibr">46</xref>] Concerning COVID-19, 52 patients out of 36 studies were described to have different variants of GBS. (
 <xref rid="t0020" ref-type="table">Table 4</xref>) Miller Fisher Syndrome was also reported in several cases. [
 <xref rid="bb0505" ref-type="bibr">101</xref>,
 <xref rid="bb1140" ref-type="bibr">228</xref>,
 <xref rid="bb1185" ref-type="bibr">237</xref>,
 <xref rid="bb1195" ref-type="bibr">239</xref>,
 <xref rid="bb1230" ref-type="bibr">246</xref>]
</p>
